Palvella Therapeutics (PVLA) FCF Margin (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 394.00 |
| Jun 30, 2023 | 50,335.00 |
| Sep 30, 2022 | -296,749.00 |
| Jun 30, 2022 | -23,225.00 |
| Mar 31, 2022 | 3,075.00 |
| Dec 31, 2021 | 27,167.00 |
| Sep 30, 2021 | -167,960.00 |
| Jun 30, 2021 | 126,197.00 |
| Mar 31, 2021 | 65,202.00 |
| Dec 31, 2020 | -51,662.00 |
| Sep 30, 2020 | -13,261.00 |
| Jun 30, 2020 | 3,225.00 |
| Mar 31, 2020 | 36,711.00 |
| Dec 31, 2019 | -41,060.00 |
| Sep 30, 2019 | 13,365.00 |
| Jun 30, 2019 | -4,057.00 |
| Mar 31, 2019 | 142,561.00 |
| Dec 31, 2018 | -142,787.00 |
| Sep 30, 2018 | -9,571.00 |
| Jun 30, 2018 | -82,507.00 |
| Mar 31, 2018 | 77,519.00 |
| Dec 31, 2017 | -91,935.00 |
| Sep 30, 2017 | 127,672.00 |
| Jun 30, 2017 | -229,333.00 |
| Mar 31, 2017 | 216,110.00 |
| Dec 31, 2016 | 22,518.00 |
| Sep 30, 2016 | 9,409.00 |
| Jun 30, 2016 | -73,189.00 |
| Mar 31, 2016 | -51,468.00 |
| Dec 31, 2015 | 157,191.00 |
| Sep 30, 2015 | 104,505.00 |
| Jun 30, 2015 | -27,540.00 |
| Sep 30, 2014 | 41,432.00 |